BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 37570694)

  • 1. Proteomics Studies Suggest That Nitric Oxide Donor Furoxans Inhibit In Vitro Vascular Smooth Muscle Cell Proliferation by Nitric Oxide-Independent Mechanisms.
    Lazzarato L; Bianchi L; Andolfo A; Granata A; Lombardi M; Sinelli M; Rolando B; Carini M; Corsini A; Fruttero R; Arnaboldi L
    Molecules; 2023 Jul; 28(15):. PubMed ID: 37570694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of redox signaling and poly (adenosine diphosphate-ribose) polymerase activation in vascular smooth muscle cell growth inhibition by nitric oxide and peroxynitrite.
    Huang J; Lin SC; Nadershahi A; Watts SW; Sarkar R
    J Vasc Surg; 2008 Mar; 47(3):599-607. PubMed ID: 18295111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of slow, sustained, and rate-tunable nitric oxide donors on human aortic smooth muscle cells proliferation.
    Yu H; Payne TJ; Mohanty DK
    Chem Biol Drug Des; 2011 Oct; 78(4):527-34. PubMed ID: 21740530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase G activity prevents pathological-level nitric oxide-induced apoptosis and promotes DNA synthesis/cell proliferation in vascular smooth muscle cells.
    Wong JC; Fiscus RR
    Cardiovasc Pathol; 2010; 19(6):e221-31. PubMed ID: 20060325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus-mediated gene transfer of cGMP-dependent protein kinase increases the sensitivity of cultured vascular smooth muscle cells to the antiproliferative and pro-apoptotic effects of nitric oxide/cGMP.
    Chiche JD; Schlutsmeyer SM; Bloch DB; de la Monte SM; Roberts JD; Filippov G; Janssens SP; Rosenzweig A; Bloch KD
    J Biol Chem; 1998 Dec; 273(51):34263-71. PubMed ID: 9852090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Halothane and isoflurane inhibit endothelium-derived relaxing factor-dependent cyclic guanosine monophosphate accumulation in endothelial cell-vascular smooth muscle co-cultures independent of an effect on guanylyl cyclase activation.
    Johns RA; Tichotsky A; Muro M; Spaeth JP; Le Cras TD; Rengasamy A
    Anesthesiology; 1995 Oct; 83(4):823-34. PubMed ID: 7574063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide attenuates endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 in vascular smooth muscle cells by a cGMP-dependent pathway.
    Bouallegue A; Daou GB; Srivastava AK
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2072-9. PubMed ID: 17644565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide stimulates matrix synthesis and deposition by adult human aortic smooth muscle cells within three-dimensional cocultures.
    Simmers P; Gishto A; Vyavahare N; Kothapalli CR
    Tissue Eng Part A; 2015 Apr; 21(7-8):1455-70. PubMed ID: 25597545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by increasing the ubiquitination and degradation of UbcH10.
    Tsihlis ND; Oustwani CS; Vavra AK; Jiang Q; Keefer LK; Kibbe MR
    Cell Biochem Biophys; 2011 Jun; 60(1-2):89-97. PubMed ID: 21448667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slow and sustained nitric oxide releasing compounds inhibit multipotent vascular stem cell proliferation and differentiation without causing cell death.
    Curtis BM; Leix KA; Ji Y; Glaves RS; Ash DE; Mohanty DK
    Biochem Biophys Res Commun; 2014 Jul; 450(1):208-12. PubMed ID: 24878532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in phenotype and gene expression of adult human aneurysmal smooth muscle cells by exogenous nitric oxide.
    Farrell K; Simmers P; Mahajan G; Boytard L; Camardo A; Joshi J; Ramamurthi A; Pinet F; Kothapalli CR
    Exp Cell Res; 2019 Nov; 384(1):111589. PubMed ID: 31473210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of exogenous nitric oxide on smooth muscle cell proliferation following porcine carotid angioplasty.
    Groves PH; Banning AP; Penny WJ; Newby AC; Cheadle HA; Lewis MJ
    Cardiovasc Res; 1995 Jul; 30(1):87-96. PubMed ID: 7553728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S-nitrosocysteamine-functionalised porous graphene oxide nanosheets as nitric oxide delivery vehicles for cardiovascular applications.
    Tabish TA; Hussain MZ; Zervou S; Myers WK; Tu W; Xu J; Beer I; Huang WE; Chandrawati R; Crabtree MJ; Winyard PG; Lygate CA
    Redox Biol; 2024 Jun; 72():103144. PubMed ID: 38613920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of nitric oxide in regulating neonatal porcine pulmonary artery smooth muscle cell proliferation.
    Ambalavanan N; Mariani G; Bulger A; Philips III JB
    Biol Neonate; 1999 Nov; 76(5):291-300. PubMed ID: 10516396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual functionality of cyclooxygenase-2 as a regulator of tumor necrosis factor-mediated G1 shortening and nitric oxide-mediated inhibition of vascular smooth muscle cell proliferation.
    Haider A; Lee I; Grabarek J; Darzynkiewicz Z; Ferreri NR
    Circulation; 2003 Aug; 108(8):1015-21. PubMed ID: 12912810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide-induced inhibition of smooth muscle cell proliferation involves S-nitrosation and inactivation of RhoA.
    Zuckerbraun BS; Stoyanovsky DA; Sengupta R; Shapiro RA; Ozanich BA; Rao J; Barbato JE; Tzeng E
    Am J Physiol Cell Physiol; 2007 Feb; 292(2):C824-31. PubMed ID: 16914531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superoxide determines nitric oxide uptake rate by vascular smooth muscle cells.
    Huang KT; Yin CC; Wu JH; Huang HH
    FEBS Lett; 2005 Aug; 579(20):4349-54. PubMed ID: 16051234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell cycle effects of nitric oxide on vascular smooth muscle cells.
    Sarkar R; Gordon D; Stanley JC; Webb RC
    Am J Physiol; 1997 Apr; 272(4 Pt 2):H1810-8. PubMed ID: 9139967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ambient pressure upregulates nitric oxide synthase in a phosphorylated-extracellular regulated kinase- and protein kinase C-dependent manner.
    Vouyouka AG; Jiang Y; Rastogi R; Basson MD
    J Vasc Surg; 2006 Nov; 44(5):1076-84. PubMed ID: 17098545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual cell cycle-specific mechanisms mediate the antimitogenic effects of nitric oxide in vascular smooth muscle cells.
    Sarkar R; Gordon D; Stanley JC; Webb RC
    J Hypertens; 1997 Mar; 15(3):275-83. PubMed ID: 9468455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.